APA (7th ed.) Citation

Ratni, H., Ebeling, M., Baird, J., Bendels, S., Bylund, J., Chen, K. S., . . . Mueller, L. (2018). Discovery of Risdiplam, a Selective Survival of Motor Neuron‑2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA). Journal of medicinal chemistry, 61(15), 6501-6517. https://doi.org/10.1021/acs.jmedchem.8b00741

Chicago Style (17th ed.) Citation

Ratni, Hasane, et al. "Discovery of Risdiplam, a Selective Survival of Motor Neuron‑2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)." Journal of Medicinal Chemistry 61, no. 15 (2018): 6501-6517. https://doi.org/10.1021/acs.jmedchem.8b00741.

MLA (9th ed.) Citation

Ratni, Hasane, et al. "Discovery of Risdiplam, a Selective Survival of Motor Neuron‑2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)." Journal of Medicinal Chemistry, vol. 61, no. 15, 2018, pp. 6501-6517, https://doi.org/10.1021/acs.jmedchem.8b00741.